Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px
All >

News > Western Europe

Please find below news about Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, the Netherlands and Switzerland as well as about organisations from these countries.

Total search results: 11465 | Ordered by Date (descending)
1 2 3 ... 113 114 115  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
CellTool GmbH. (1/20/20). "Press Release: CellTool Appoints Wulf Fischer-Knuppertz as CEO". Tutzing. 2020-01-20
Seekyo S.A.S.. (1/20/20). "Press Release: Biotech Start-up Seekyo Raises €800k with Leverage from French Tech Seed Fund". Poitiers. 2020-01-20
Osteolabs GmbH. (1/20/20). "Press Release: Osteolabs GmbH Successfully Closes First International Commercial Agreements and Starts Contract Research Collaboration with the Health Department of an European Army". Kiel. 2020-01-20
BioNTech SE. (1/16/20). "Press Release: BioNTech to Acquire Neon to Strengthen Global Leadership Position in T Cell Therapies". Mainz & Cambridge, MA. 2020-01-16
Sophia Genetics S.A.. (1/15/20). "Press Release: IDT Partners with Sophia Genetics to Increase Access to Clinical-grade Technologies". Coralville, IA. 2020-01-15
Jeito Capital. (1/15/20). "Press Release: Rafaèle Tordjman Launches Jeito Capital, a New Private Equity Company Dedicated to Biotech-biopharmaceuticals, and Announces the Closing of Jeito I at €200 Million". Paris. 2020-01-15
Urania Therapeutics S.A.S.. (1/14/20). "Press Release: Urania Therapeutics Benefits from €1.7M Deeptech Financing from Bpifrance". Strasbourg. 2020-01-14
Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. 2020-01-14
Curetis N.V.. (1/14/20). "Press Release: Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.". Amsterdam, Holzgerlingen & San Diego, CA. 2020-01-14
Domain Therapeutics S.A.. (1/13/20). "Press Release: Domain Therapeutics Secures €6 Million ($6.7M) Debt Financing". Strasbourg. 2020-01-13
MorphoSys AG. (1/13/20). "Press Release: MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab". Planegg & Wilmington, DE. 2020-01-13
Waters Corporation. (1/13/20). "Press Release: Waters to Acquire Andrew Alliance". Milford, MA. 2020-01-13
Cellectis S.A.. (1/12/20). "Press Release: Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement". San Carlos, CA & New York, NY. 2020-01-12
NBE Therapeutics AG. (1/10/20). "Press Release: NBE-Therapeutics Closes a USD 22M Series C Financing Round". Basel. 2020-01-10
Bayer AG. (1/9/20). "Press Release: Bayer and Exscientia Collaborate to Leverage the Potential of Artificial Intelligence in Cardiovascular and Oncology Drug Discovery". Berlin. 2020-01-09
Novadiscovery S.A.S.. (1/9/20). "Press Release: Novadiscovery Raises Series A Financing to Scale Its in silico Clinical Trial Platform – Debiopharm Leads the Round with EUR 5 Million". 2020-01-09
Nurix Therapeutics, Inc.. (1/9/20). "Press Release: Nurix Therapeutics and Sanofi Establish Strategic Collaboration to Develop Novel Targeted Protein Degradation Therapies". San Francisco, CA. 2020-01-09
Selexis S.A.. (1/9/20). "Press Release: Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer". Geneva. 2020-01-09
Boehringer Ingelheim. (1/9/20). "Press Release: Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases". Ingelheim & Singapore. 2020-01-09
Alderaan Biotechnology S.A.S.. (1/9/20). "Press Release: Alderaan Biotechnology Raises €18.5m in Series A from Advent France Biotechnology (AFB) and Medicxi". Paris. 2020-01-09
Evotec SE. (1/9/20). "Press Release: Bayer and Evotec Form New Strategic Alliance Focusing on Polycystic Ovary Syndrome". Hamburg & Berlin. 2020-01-09
Grey Wolf Therapeutics Ltd.. (1/9/20). "Press Release: Grey Wolf Completes £2.5 Million Series A2 Financing for Development of Therapies Targeting ERAP2". Oxford. 2020-01-09
Esteve Pharmaceuticals, S.A.. (1/8/20). "Press Release: Esteve Acquires German Proprietary, Specialty, Hospital-focused Company Riemser and Expands Its Presence in Europe". 2020-01-08
Eyevensys S.A.S.. (1/8/20). "Press Release: Eyevensys Closes $30M Series B Financing". Paris & Fort Worth, TX. 2020-01-08
ProBioGen AG. (1/8/20). "Press Release: ProBioGen Inks Next Commercial GlymaxX License with Roche. ADCC-enhancement for Innovative Cancer Therapy". Berlin. 2020-01-08
Wellington Partners. (1/8/20). "Press Release: Karl Naegler Joins Wellington Partners as Managing Partner". Munich. 2020-01-08
BC Platforms. (1/8/20). "Press Release: BC Platforms Partners with Dante Labs to Build Europe's Largest Next Generation Sequencing Laboratory for Private and Public Customers". Zürich & Boston, MA. 2020-01-08
NorthSea Therapeutics B.V.. (1/8/20). "Press Release: NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA Study in NASH and to Advance Two Additional SEFAs into the Clinic". Naarden. 2020-01-08
Velabs Therapeutics GmbH. (1/7/20). "Press Release: Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics". Heidelberg & Jena. 2020-01-07
Evotec SE. (1/7/20). "Press Release: Evotec and Bristol-Myers Squibb Expand iPSC Collaboration". Hamburg. 2020-01-07
CureVac AG. (1/7/20). "Press Release: CureVac Announces Positive Results in Low Dose – 1 µg – Rabies Vaccine Clinical Phase 1 Study". Tübingen & Boston, MA. 2020-01-07
PhoreMost Ltd.. (1/7/20). "Press Release: PhoreMost and Boehringer Ingelheim Enter Multi-project Drug Discovery Collaboration". Cambridge. 2020-01-07
Bayer AG. (1/7/20). "Press Release: Bayer Exercises Right to Enter into Follow-on Research and Collaboration Option Agreement with Atomwise. Companies to Continue Crop Protection Development Programs". Monheim & San Francisco, CA. 2020-01-07
VectivBio AG. (1/7/20). "Press Release: VectivBio Launches with $35M Financing to Bring Best-in-Disease Medicines to Patients with Serious Rare Diseases". Basel. 2020-01-07
genOway S.A.. (1/7/20). "Press Release: genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models". Lyon. 2020-01-07
Novo Holdings A/S. (1/6/20). "Press Release: Novo Holdings REPAIR Impact Fund Invests USD 12 Million in Mutabilis and IBT Vaccines and Provides Strategic Update". Copenhagen. 2020-01-06
MorphoSys AG. (12/30/19). "Press Release: MorphoSys Announces Submission of Biologics License Application for Tafasitamab in r/r DLBCL to the FDA". Planegg. 2019-12-30
Codexis, Inc.. (12/23/19). "Press Release: Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing". Redwood City, CA. 2019-12-23
Genmab A/S. (12/19/19). "Press Release: Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics". Copenhagen & Tübingen. 2019-12-19
Merck KGaA. (12/19/19). "Press Release: Merck Licenses Foundational CRISPR Integration Technology to Promega". Darmstadt. 2019-12-19
Bone Therapeutics S.A.. (12/19/19). "Press Release: Bone Therapeutics Announces the Appointment of Dr. Miguel Forte as CEO to Lead the Company into the Next Phase of Development". Gosselies. 2019-12-19
Ferring Pharmaceuticals S.A.. (12/18/19). "Press Release: FerGene Appoints David Meek Chief Executive Officer". Cambridge, MA. 2019-12-18
MolMed S.p.A.. (12/18/19). "Press Release: Italy – the EIB Supports MolMed Investment in Research, Development and Manufacturing for Cancer and Rare Diseases Innovative Treatments". Oxford. 2019-12-18
Evotec SE. (12/18/19). "Press Release: Evotec Expands Service Agreement with Sanofi to Create a Centralised Global Sample Management Hub in Toulouse". Hamburg. 2019-12-18
Ipsen S.A.. (12/18/19). "Press Release: Ipsen Announces Departure of David Meek as Chief Executive Officer". Paris. 2019-12-18
Boehringer Ingelheim. (12/18/19). "Press Release: Boehringer Ingelheim Discontinues Development of BI 1467335 for NASH". Ingelheim & Sydney. 2019-12-18
BC Platforms. (12/18/19). "Press Release: BC Platforms Closes $15 Million Series C Financing and Signs Partnership with Iqvia to Extend Data Analytics in Genomics". Zürich & Boston, MA. 2019-12-18
Truffle Capital. (12/18/19). "Press Release: Truffle Capital Successfully Raises nearly €400 Million for New Venture Capital Funds Funds backed by top-tier French and international institutional investors". Paris. 2019-12-18
Cellestia Biotech AG. (12/17/19). "Press Release: Successful Closing of Series B Financing Round with CHF 20M". Basel. 2019-12-17
Resistell AG. (12/17/19). "Press Release: Resistell AG Closes CHF 3.5M Series A Financing Round". 2019-12-17
Roche. (12/17/19). "Press Release: Roche Concludes Acquisition of Spark Therapeutics, Inc. to Strengthen Presence in GeneTherapy". Basel. 2019-12-17
Augustine Therapeutics. (12/16/19). "Press Release: VIB and KU Leuven Announce New Spin-off Augustine Therapeutics to Fight Neuromuscular Diseases". Belgium. 2019-12-16
Sphingotec GmbH. (12/16/19). "Press Release: Sphingotec’s Proprietary Biomarker bio-ADM Detects Residual Congestion in Patients with Heart Failure". Hennigsdorf. 2019-12-16
Promethera Biosciences S.A.. (12/16/19). "Press Release: Promethera Attracts Sony Innovation Fund by IGV and Pegasus Tech Ventures as New Investors in Final Closing of Series D . Total Amount Raise in the Series D Reaches €47.2 Million". Mont-Saint-Guibe 2019-12-16
Sidekick Health. (12/16/19). "Press Release: Sidekick Partners with Bayer to Provide Digital Therapy Expansion for PAD Patients". 2019-12-16
Boehringer Ingelheim. (12/13/19). "Press Release: Boehringer Ingelheim and Lilly Provide Update on Empagliflozin Phase III Exercise Ability Studies in Chronic Heart Failure". Ingelheim & Indianapolis, IN. 2019-12-13
Aelis Farma. (12/13/19). "Press Release: Aelis Farma Raises €11 Million to Accelerate the Clinical Development of a Paradigm-Shifting New Class of Drugs for Treating Cannabis Addiction and Cognitive Disorders". Bordeaux. 2019-12-13
Innate Pharma S.A.. (12/13/19). "Press Release: Innate Pharma Provides Update on Lacutamab TELLOMAK Trial". Marseille. 2019-12-13
Immunicum AB. (12/13/19). "Press Release: Immunicum AB (publ) Announces Resignation of Carlos de Sousa as CEO". 2019-12-13
Genmab A/S. (12/13/19). "Press Release: CHMP Issues Positive Opinion Recommending Darzalex (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma". Copenhagen. 2019-12-13
iTeos Therapeutics S.A.. (12/12/19). "Press Release: iTeos Therapeutics Announces Collaboration with Merck Investigating the Combination of its A2A Antagonist with Keytruda". Gosselies & Cambridge, MA. 2019-12-12
Bioncotech Therapeutics S.L.. (12/12/19). "Press Release: Bioncotech Therapeutics Phase I BO-112 Data Presented at ESMO Immuno-Oncology Congress 2019". Madrid. 2019-12-12
Numab Therapeutics AG. (12/12/19). "Press Release: Numab Therapeutics and 3SBio’s Subsidiary Sunshine Guojian Form Partnership to Develop a Portfolio of Novel Multi-specific Antibodies in Immuno-Oncology". Wädenswil, Shengyang & Shanghai. 2019-12-12
Stilla Technologies S.A.S.. (12/10/19). "Press Release: Stilla Technologies Names Key Leadership Slate to Support Global Growth of its Next-Generation Digital PCR Solution". Paris. 2019-12-10
Creoptix AG. (12/10/19). "Press Release: Creoptix Appoints Line Stigen Raquet as Chief Executive Officer". Wädenswil (Zurich). 2019-12-10
TU Braunschweig. (12/10/19). "Pressemitteilung: Start-up zu nachhaltiger Antikörper-Produktion Ausgründung der TU Braunschweig arbeitet an breiter Anwendung". 2019-12-10
ImmunOs Therapeutics AG. (12/10/19). "Press Release: ImmunOs Therapeutics AG Raises CHF 15M in Series A Financing, Co-led by Pfizer Ventures and BioMedPartners, to Advance a Novel Immunotherapy Agent For Cancer into Human Trials". Schlieren. 2019-12-10
Bruker Corporation. (12/9/19). "Press Release: Bruker Introduces Dedicated Light-Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging". Washington, DC. 2019-12-09
ObsEva S.A.. (12/9/19). "Press Release: ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix". Geneva & Boston, MA. 2019-12-09
Algiax Pharmaceuticals. (12/9/19). "Press Release: Algiax Is Ready to Go Into Proof-of-Concept for AP-325 and Welcomes New Investors". Düsseldorf. 2019-12-09
Sanofi S.A.. (12/9/19). "Press Release: Sanofi to Acquire Synthorx to Bolster Its Immuno-oncology Pipeline for $2.5 Billion". Paris & San Diego, CA. 2019-12-09
Eppendorf AG. (12/6/19). "Press Release: Eppendorf with New CEO Dual Leadership. Eva van Pelt and Dr. Peter Fruhstorfer Appointed Co-CEOs – Former CEO, Thomas Bachmann, Left the Company". Hamburg. 2019-12-06
Deinove S.A.. (12/6/19). "Press Release: Evolution in Deinove’s Governance. Emmanuel Petiot Will Resign as Chief Executive Officer ("CEO") as of December 31, 2019". Montpellier. 2019-12-06
BC Platforms. (12/6/19). "Press Release: BC Platforms Partners with Leading European Genomics Service Provider Center Life & Brain to Expand Genotyping Services Across Europe". Zürich & Boston, MA. 2019-12-06
Sartorius AG. (12/5/19). "Press Release: Sartorius Acquires a Majority Stake in Cell Culture Media Specialist Biological Industries". Göttingen. 2019-12-05
4Teen4 Pharmaceuticals GmbH. (12/5/19). "Press Release: Biotech Startup 4Teen4 Pharmaceuticals Closes EUR 7 Million Series A Financing". Hennigsdorf. 2019-12-05
Sartorius AG. (12/5/19). "Press Release: Sartorius Supervisory Board Extends Appointment of Group CEO Joachim Kreuzburg". Göttingen. 2019-12-05
ImCheck Therapeutics S.A.S.. (12/4/19). "Press Release: ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases". Marseille. 2019-12-04
Kuros Biosciences Ltd.. (12/3/19). "Press Release: Kuros Announces Final Result of Capital Increase – Total Gross Proceeds of CHF 12.5 Million Raised [Not for US, UK, AU, et al.]". Schlieren. 2019-12-03
Mologen AG. (12/3/19). "Press Release: Insolvency Filing [Not for publication or distribution in or into US, AU, CA or JP or any jurisdiction in which unlawful]". Berlin. 2019-12-03
Owkin. (12/2/19). "Press Release: Owkin Teams up with NVIDIA and King's College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning". Paris & New York. 2019-12-02
Puma Biotechnology, Inc.. (12/2/19). "Press Release: Puma Biotechnology Amends License Agreement with Pierre Fabre to Include Additional Countries". Berlin. 2019-12-02
Ligand Pharmaceuticals Inc.. (12/2/19). "Press Release: Ligand Enters into Worldwide OmniAb Platform License Agreement with Sanofi". San Diego, CA. 2019-12-02
CureVac AG. (12/2/19). "Press Release: CureVac Granted Manufacturing Authorization for Its Third GMP Production Suite". Tübingen & Boston, MA. 2019-12-02
Indivumed GmbH. (12/2/19). "Press Release: Indivumed Announces Strategic Partnership with Biognosys". Hamburg & Schlieren. 2019-12-02
Diabeloop S.A.. (12/2/19). "Press Release: Diabeloop Completes Record-breaking European Fundraising Effort With Its Autonomous Diabetes Management Solutions". Grenoble. 2019-12-02
Sensorion S.A.. (12/2/19). "Press Release: Sensorion Announces Results From SENS-111 Phase 2b Trial in Acute Unilateral Vestibulopathy". Montpellier. 2019-12-02
BRAIN AG. (12/2/19). "Press Release: New Chairman of the Management Board – Adriaan Moelker Takes Over from Dr Jürgen Eck". Zwingenberg. 2019-12-02
Max-Delbrück-Centrum für Molekulare Medizin (MDC). (12/2/19). "Press Release: Deep Learning Identifies Molecular Patterns of Cancer". Berlin. 2019-12-02
European Invesmtent Bank (EIB). (11/29/19). "Press Release: A European Fund to Support the Circular Bioeconomy". 2019-11-29
ViGeneron GmbH. (11/28/19). "Press Release: ViGeneron Announces Closing of Series A Financing to Drive Development of Next Generation Gene Therapy Pipeline". Munich. 2019-11-28
MedinCell S.A.. (11/28/19). "Press Release: MedinCell Receives $19 Million Grant for Its mdc-WWM Program". Montpellier. 2019-11-28
Avantium N.V.. (11/28/19). "Press Release: Avantium Secures Financing Milestone with €25 million EU Funding for FDCA Flagship Plant". Amsterdam. 2019-11-28
Qiagen N.V.. (11/27/19). "Press Release: Qiagen and DiaSorin Receive FDA Approval for the Liaison QuantiFERON-TB Gold Plus Test on Liaison Platforms and Begin Commercial Launch". Germantown, MD, Hilden & Saluggia. 2019-11-27
Helmholtz-Zentrum für Infektionsforschung (HZI. (11/27/19). "Press Release: Helmholtz Gets Three more Start-ups Off the Ground. HZI Spin-off Myxobiotics Researches Active Substance against Urinary Tract Infections". 2019-11-27
Lonza Group Ltd.. (11/26/19). "Press Release: Lonza and Dinaqor Announce Strategic Collaboration to Advance Gene Therapy Programs for Patients with Monogenic Cardiomyopathies". Basel & Pfäffikon. 2019-11-26
SHS Gesellschaft für Beteiligungsmanagement mbH. (11/26/19). "Press Release: Establishing a New Standard for the Life Science Industry. SHS Supports Internationalization and Further Growth of Single Use Support". Tübingen & Kufstein. 2019-11-26
MaxiVax S.A.. (11/26/19). "Press Release: MaxiVax Awarded €2,785,000 European Commission Grant and Announces Successful Closing of Its Series B 2 Round for an Amount of CHF 5 Million". Geneva. 2019-11-26
Merck KGaA. (11/26/19). "Press Release: Japan and Singapore Grant CRISPR Patents to Merck". Darmstadt. 2019-11-26
Roche. (11/25/19). "Press Release: FDA Grants Priority Review to Roche’s Risdiplam for Spinal Muscular Atrophy". Basel. 2019-11-25
1 2 3 ... 113 114 115  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

» top